by The Tamiflu (Oseltamivir Phosphate) is an antiviral medication used to treat and prevent influenza A and influenza B. Tamiflu helps reduce the duration and severity of flu symptoms. It works by preventing the spread of flu virus in the body. With increasing prevalence of influenza globally due to factors such as climate change and virus mutations, the need for effective treatment and prevention of flu has surged tremendously.
The global Tamiflu (Oseltamivir Phosphate) Market is estimated to be valued at US$ 464.4 Mn in 2023 and is expected to exhibit a CAGR of 6.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing incidence of influenza across the world has propelled the demand for Tamiflu (Oseltamivir Phosphate) significantly over the past few years. As per the data by the World Health Organization (WHO), influenza infects nearly 1 billion people worldwide each year, leading to 3-5 million cases of severe illness and around 290,000 to 650,000 deaths globally. Moreover, different strains of influenza virus emerge frequently due to mutations, which contributes to new epidemics. Continued investments by market players in R&D of more effective formulations of Tamiflu (Oseltamivir Phosphate) and growing healthcare expenditure in developing countries are some of the factors estimated to drive the market growth over the forecast period.
SWOT Analysis
Strength: Tamiflu is an effective anti-influenza drug that acts against influenza A and B viruses. It works by blocking the activity of neuraminidase, an enzyme on the surface of influenza viruses.
Weakness: Tamiflu is not a cure and only reduces flu symptoms and shortens the duration of the illness by one day. It is less effective for people who start treatment more than 48 hours after flu symptoms begin.
Opportunity: Increasing awareness about influenza prevention provides opportunities to expand the use of Tamiflu as a prophylactic before and after exposure to influenza. Growing pandemic preparedness efforts also support increased adoption.
Threats: Drug resistance remains a threat as influenza viruses are constantly mutating. Other competing antiviral drugs also pose market threats. Negative press related to drug safety concerns can impact sales.
Key Takeaways
The Global Tamiflu Market Size is expected to witness high growth over the forecast period of 2023 to 2030 supported by increasing incidence of influenza worldwide. The market was valued at US$ 464.4 Mn in 2024 and is anticipated to grow at a CAGR of 6.3% through 2030.
Regional analysis: North America currently dominates the global Tamiflu market owing to rising healthcare investments and high adoption rates of vaccination and antiviral drugs for influenza prevention. The Asia Pacific region is expected to exhibit the fastest growth over the coming years due to improving access to healthcare and growing medical toursim in countries like India, Thailand and Singapore.
Key players: Key players operating in the Tamiflu market include HCA Healthcare, Ascension Health, Kaiser Permanente, and Mayo Clinic. Market leaders are focusing on new drug formulations, co-marketing collaborations and geographical expansion strategies to strengthen their market positions and cater to the increasing global demand for Tamiflu.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
